These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12971587)

  • 1. Hypertension: prevalence and economic implications.
    Dalzell MD
    Manag Care; 2003 Aug; 12(8 Suppl Hypertension):6-11. PubMed ID: 12971587
    [No Abstract]   [Full Text] [Related]  

  • 2. Economic burden of comorbidities in patients with psoriasis is substantial.
    Kimball AB; Guérin A; Tsaneva M; Yu AP; Wu EQ; Gupta SR; Bao Y; Mulani PM
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):157-63. PubMed ID: 20561129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urologic diseases in America project: urinary incontinence in males--demographics and economic burden.
    Stothers L; Thom D; Calhoun E
    J Urol; 2005 Apr; 173(4):1302-8. PubMed ID: 15758786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of illness of hypertension among women using menopausal hormone therapy: a US perspective.
    Hawkins K; Mittapally R; Chang J; Nahum GG; Gricar J
    Curr Med Res Opin; 2010 Dec; 26(12):2823-32. PubMed ID: 21058896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost of treating high blood pressure in general practice in France.
    Tibi-Levy Y; de Pouvourville G; Westerloppe J; Bamberger M
    Eur J Health Econ; 2008 Aug; 9(3):229-36. PubMed ID: 17566802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of health risk on medical costs.
    Anderson D; Brink S; Courtney TD
    Med Interface; 1995 Dec; 8(12):121-2. PubMed ID: 10153517
    [No Abstract]   [Full Text] [Related]  

  • 7. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1999--2000.
    Burt CW; Schappert SM
    Vital Health Stat 13; 2004 Sep; (157):1-70. PubMed ID: 15499797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urologic diseases in America project: urolithiasis.
    Pearle MS; Calhoun EA; Curhan GC;
    J Urol; 2005 Mar; 173(3):848-57. PubMed ID: 15711292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year comparison of estimates of overweight and obesity, diagnosed diabetes and use of office-based physician services for treatment of diabetes in the United States.
    Pearson WS
    Prev Med; 2007 Nov; 45(5):353-7. PubMed ID: 17707497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension epidemiology and economic burden: refining risk assessment to lower costs.
    Cohen JD
    Manag Care; 2009 Oct; 18(10):51-8. PubMed ID: 19902690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dry eye: prevalence, utilization, and economic implications.
    Dalzell MD
    Manag Care; 2003 Dec; 12(12 Suppl):9-13. PubMed ID: 14723108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of different pharmacological treatment strategies in elderly hypertensives.
    Linjer E; Hedner T; Jönsson B; Ekbom T; Lindholm LH; Dahlöf B; de Faire U; Scherstén B;
    Blood Press; 2005; 14(2):107-13. PubMed ID: 16036488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical and economic burden of fibromyalgia compared with diabetes mellitus and hypertension among Bedouin women in the Negev.
    Doron Y; Peleg R; Peleg A; Neumann L; Buskila D
    Fam Pract; 2004 Aug; 21(4):415-9. PubMed ID: 15249530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension control at physicians' offices in the United States.
    Fang J; Alderman MH; Keenan NL; Ayala C; Croft JB
    Am J Hypertens; 2008 Feb; 21(2):136-42. PubMed ID: 18188159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The medical cost of cardiometabolic risk factor clusters in the United States.
    Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
    Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of illness associated with hepatocellular carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Shah S; Thompson D
    J Hepatol; 2009 Jan; 50(1):89-99. PubMed ID: 18977551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Budget impact of tegaserod on a managed care organization formulary.
    Bloom MA; Barghout V; Kahler KH; Bentkover J; Kurth H; Gralnek IM; Spiegel BM
    Am J Manag Care; 2005 Apr; 11(1 Suppl):S27-34. PubMed ID: 15926761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nondialysis (home) medication utilization and cost in diabetic and nondiabetic hemodialysis patients.
    Manley HJ; Cannella CA
    Nephrol News Issues; 2005 Jan; 19(2):27-8, 33-4, 36-8. PubMed ID: 15717572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Ambulatory Medical Care Survey: 2002 summary.
    Woodwell DA; Cherry DK
    Adv Data; 2004 Aug; (346):1-44. PubMed ID: 15460863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.